GleamWall
中文EN

BETRF BetterLife Pharma Inc. IFRS

Pharmaceutical Preparations · OTC · SEC CIK 1464165 · Reporting currency CAD · Fiscal year ends 01/31

Financial factors as of 2025-01-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-21.9%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-1,280.8%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets3,372.6%
Debt / equity—
Current ratio—
Interest coverage-30.29x

Cash quality & payout

Operating cash flow / net income0.57x
Accruals ratio-545.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: CAD FY2025*2025-01-31FY2024*2024-01-31
Income statement
Revenue——
R&D expense424,337570,947
SG&A expense260,500271,731
Operating income-5.00M-3.24M
Interest expense165,08745,544
Pretax income—-2.90M
Net income-3.52M-2.89M
EBITDA-5.00M-3.24M
EPS (diluted)-0.03-0.03
Balance sheet
Cash & equivalents8,18037,384
Receivables11,64439,536
Total assets224,963324,746
Current liabilities7.54M7.35M
Short-term debt—50,052
Long-term debt—49,115
Total debt—99,167
Total liabilities7.59M8.02M
Shareholders' equity-10.68M-10.81M
Net debt—61,783
Shares outstanding43.49M52.81M
Cash flow statement
Operating cash flow-2.02M-2.47M
Financing cash flow1.99M2.50M
Depreciation & amortization00
Stock-based compensation2.05M500,263

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company does not report gross profit in XBRL.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.